Literature DB >> 1572694

Interferon-gamma (IFN-gamma) production in vivo in experimental autoimmune uveoretinitis.

D G Charteris1, S L Lightman.   

Abstract

Experimental autoimmune uveoretinitis (EAU) is a well-characterized model of immune-mediated intraocular inflammation. The intraocular infiltrate in EAU consists predominantly of T lymphocytes. The in vivo production of interferon-gamma (IFN-gamma) by these T cells was investigated immunohistochemically and by in situ hybridization using a cDNA probe to rat IFN-gamma mRNA. Positive localization of IFN-gamma mRNA began simultaneously with disease onset and increased as the inflammatory tissue destruction progressed. The positive signal was seen on cells in the retina, uveal tract and extraocular region where collections of inflammatory cells contained many T lymphocytes. Numerous cells in these locations also stained positively immunohistochemically for IFN-gamma. These results indicate that the in vivo production of IFN-gamma within the eye could play a role in the immune regulation of intraocular inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572694      PMCID: PMC1384740     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Interferon: a cytotoxic T lymphocyte differentiation signal.

Authors:  L K Chen; B Tourvieille; G F Burns; F H Bach; D Mathieu-Mahul; M Sasportes; A Bensussan
Journal:  Eur J Immunol       Date:  1986-07       Impact factor: 5.532

Review 2.  Phenotypic and functional heterogeneity of CD4+ T cells.

Authors:  F Powrie; D Mason
Journal:  Immunol Today       Date:  1988-09

3.  Memory CD4+ T cells in man form two distinct subpopulations, defined by their expression of isoforms of the leucocyte common antigen, CD45.

Authors:  D Mason; F Powrie
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

4.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

5.  HLA-DR antigens on retinal pigment epithelial cells from patients with uveitis.

Authors:  C C Chan; B Detrick; R B Nussenblatt; A G Palestine; L S Fujikawa; J J Hooks
Journal:  Arch Ophthalmol       Date:  1986-05

6.  Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma.

Authors:  J M Liversidge; H F Sewell; J V Forrester
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

7.  Expression of Ia antigen on retinal pigment epithelium in experimental autoimmune uveoretinitis.

Authors:  C C Chan; J J Hooks; R B Nussenblatt; B Detrick
Journal:  Curr Eye Res       Date:  1986-04       Impact factor: 2.424

8.  Production of lymphokine mRNA by CD45R+ and CD45R- helper T cells from human peripheral blood and by human CD4+ T cell clones.

Authors:  M Salmon; G D Kitas; P A Bacon
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

9.  The MRC OX-22- CD4+ T cells that help B cells in secondary immune responses derive from naive precursors with the MRC OX-22+ CD4+ phenotype.

Authors:  F Powrie; D Mason
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Cloning and expression of the chromosomal immune interferon gene of the rat.

Authors:  R Dijkema; P H van der Meide; P H Pouwels; M Caspers; M Dubbeld; H Schellekens
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  9 in total

1.  Effect of lymphocytic infiltration on the blood-retinal barrier in experimental autoimmune uveoretinitis.

Authors:  S Lightman; J Greenwood
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

2.  Suppression of actively induced experimental autoimmune uveoretinitis by CD4+ T cells.

Authors:  E Uchio; M Kijima; M Ishioka; S Tanaka; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-02       Impact factor: 3.117

3.  Comparison of the expression of interferon gamma, IL2, IL4, and lymphotoxin mRNA in experimental autoimmune uveoretinitis.

Authors:  D G Charteris; S L Lightman
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

4.  Effects of a new dexamethasone-delivery system (Surodex) on experimental intraocular inflammation models.

Authors:  Masuhiro Kodama; Jiro Numaga; Atsushi Yoshida; Toshikatsu Kaburaki; Tetsuro Oshika; Yujiro Fujino; Guey-Shuang Wu; Narsing A Rao; Hidetoshi Kawashima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-04       Impact factor: 3.117

5.  Isolation of retinal lymphocytes in experimental autoimmune uveoretinitis: phenotypic and functional characterization.

Authors:  K Barton; V L Calder; S Lightman
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

6.  Expression of TNF-alpha, IL-1beta, and IFN-gamma in Staphylococcus epidermidis slime-positive experimental endophthalmitis is closely related to clinical inflammatory scores.

Authors:  Ioannis K Petropoulos; Chrysoula V Vantzou; Fotini N Lamari; Nikolaos K Karamanos; Evangelos D Anastassiou; Nikolaos M Pharmakakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-17       Impact factor: 3.117

7.  Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections.

Authors:  K Geiger; E L Howes; N Sarvetnick
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  In vivo lymphokine production in experimental autoimmune uveoretinitis.

Authors:  D G Charteris; S L Lightman
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

9.  AAV8-Mediated Angiotensin-Converting Enzyme 2 Gene Delivery Prevents Experimental Autoimmune Uveitis by Regulating MAPK, NF-κB and STAT3 Pathways.

Authors:  Yiguo Qiu; Lifei Tao; Shijie Zheng; Ru Lin; Xinyu Fu; Zihe Chen; Chunyan Lei; Jiaming Wang; Hongwei Li; Qiuhong Li; Bo Lei
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.